Press Releases

Filters
June 21, 2023

Altis Labs Raises US $6 Million in Seed Funding Co-Led by Debiopharm and Benchstrength to Advance AI Platform for Clinical…

Read more
June 1, 2023

Debiopharm Shares Oncology Program Updates at ASCO 2023 for Novel WEE1 Inhibitor, and First-In-Class CA IX Theranostic Approach

Read more
May 30, 2023

Debiopharm Launches Phase 1 Research in Small Cell Lung Cancer with WEE1 inhibitor Debio 0123 to Outsmart DDR

Read more
May 25, 2023

Debiopharm Partners with Genedata to Digitalize Translational Research

Read more
May 17, 2023

Debiopharm Launches Phase 1/2 Combination Trial Investigating Brain-Penetrant Selective WEE1 Inhibitor for Brain Cancer Patients

Read more
March 29, 2023

Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response

Read more
March 22, 2023

Debiopharm Announces Launch of the Phase 1/2 GaLuCi Study for its CAIX-Targeted Radiopharmaceutical Program

Read more
March 9, 2023

Iktos announces closing of € 15.5M series A round co-led by M Ventures and Debiopharm

Read more
March 2, 2023

Debiopharm extends their DNA damage repair footprint with new oncology pipeline entry

Read more